Zusammenfassung
Grundlagen
Die chronische Pankreatitis (cP) mit dem Leitsymptom des heftigen intermittierenden oder chronischen Oberbauchschmerzes ist zu 90% in industrialisierten Ländern ätiologisch durch einen chronischen Alkoholabusus bedingt.
Methodik
Die Diagnostik und Standards der konservativen Therapie bei cP werden in einer Übersicht dargestellt.
Ergebnisse
Neben dem klinischen Bild der cP basiert die Diagnostik zunächst auf bildgebenden Verfahren wie Sonographie, Computertomographie und insbesondere endoskopisch retrograde Pankreatikographie (ERP). Zur diagnostischen Evaluierung einer bestehenden exokrinen Pankreasinsuffizienz mit dem klinischen Bild des Gewichtsverlustes und Steatorrhoe dienen nicht-invasive und invasive Funktionsuntersuchungen. Die Therapie der Schmerzen bei cP gestaltet sich zunächst konservativ. Eine strikte Alkoholkarenz stellt den dietätischen Grundstein der günstigen Beeinflussung dar. Darüber hinaus werden in der Schmerztherapie neben einer symptomatisch analgetischen Behandlung auch Pankreasenzyme eingesetzt, die die endogene Pankreasstimulation durch einen negativen feed-back-Mechanismus hemmen sollen. Die exokrine Pankreasinsuffizienz wird durch die Gabe von Pankreasenzymen behandelt, wobei eine ausreichende Menge Lipase den wichtigsten Substitutionsfaktor darstellt. Es werden mindestens 40.000 IE Lipase zu normalen Mahlzeiten empfohlen. Darreichungsform und-menge sollten jedoch im Einzelfall angepaßt werden.
Schlu\folgerungen
Bei cP ist ein systematisches und individuell angepa\tes therapeutisches Vorgehen notwendig, was insbesondere beim Vorliegen von Sekundärkomplikationen einen interdisziplinären therapeutischen Ansatz nach sich ziehen kann.
Summary
Background
The main clinical symptom of chronic pancreatitis (cp) is upper abdominal pain, and in 90% chronic alcohol abuse is the etiological factor especially in industrialized countries.
Methods
The diagnosis and standards of conservative treatment in chronic pancreatitis are reviewed.
Results
Beside the typical clinical picture of the disease diagnosis is based on imaging procedures to visualize the pancreas including ultrasonography, computed tomography and endoscopic retrograde pancreatography (ERP). Diagnostic evaluation of pancreatic insuffiency accompanied by the clinical picture of weight loss and steatorrhea is completed by noninvasive and invasive function tests. Therapy of chronic pain in cp is usually based on conservative treatment. A strict alcohol abstinence is the first dietetic measure in the management of pain. Further steps are a symptomatic analgetic treatment, and administration of pancreatic enzymes, which are able to inhibit pancreatic secretion via negative feed back mechanisms. Exocrine pancreatic insuffiency is treated by dietetic measures together with an adequate pancreatic enzyme substitution, whereas lipase activity is the most important factor. A sufficient lipase substitution requires at least 40.000 IE given together with the meals. Attention must be directed to dose and preparation of pancreatic enzymes being used.
Conclusions
The principle treatment of cp should be adjusted individually and requires a systematic approach. Complications of cp and their treatment should be discussed in an interdisciplinary way of thinking including surgical interventions.
Literatur
Gowland M, Kalantzis N, Warwick F, Braganza J: Relative efficiency and predictive value of ultrasonography and endoscopic retrograde pancreatography in diagnosis of pancreatic disease. Lancet 1981;2:190–193
Otte M: Ultrasound in chronic pancreatitis. In: Diagnostic procedures in pancreatic disease. Malfertheiner, P und Ditschuneit, H (eds.), Springer-Verlag, Berlin, Heidelberg, New York, 1986, pp 143–148.
Bolondi L, Priori P, Gullo L et al.: Relationship between morphological changes detected by ultrasonography and pancreatic exocrine function in chronic pancreatitis. Pancreas 1987;2:222–229.
Alpern MB, Sandler MA, Heilman GM et al.: Chronic pancreatitis: ultrasonic features. Radiology 1985;155:215–219.
Malfertheiner P, Büchler M: Correlation of imaging and function in chronic pancreatitis. Radiol Clin N Am 1989;27:51–64.
Ammann RW, Akovbiantz A, Largiader R, Schueler G: Course and outcome of chronic pancreatitis. Gastroenterology 1984;96:820–828.
Hessel SJ, Siegelmann SS, McNeil BJ: A prospective evaluation of computed tomography and ultrasound of the pancreas. Radiology 1982;143:129–133.
Freeny PC, Marks WM: Computed tomography of chronic pancreatitis. In: Sarles H, Singer M and Gyr K (eds), Pancreatitisconcepts and classification. Elesevier, Amsterdam, 1984, pp 219–223.
Malfertheiner P, Büchler M, Stanescu A, Ditschuneit H: Exocrine pancreatic function in correlation with ductal and parenchymal morphology in chronic pancreatitis. Hepatogastroeneterology 1986;33:110–114.
Axon ATR, Classen M, Cotton PB, Cremer M, Freeny PC, Less WR: Pancreatography in chronic pancreatitis: international definitions. Gut 1984;25:1107–1112.
Malfertheiner P, Büchler M, Beger HG, Ditschuneit H: Exocrine pancreatic function in correlation to morphological findings (assessed by different imaging procedures) in chronic pancreatitis. In: Sarles H, Singer M, Gyr K (eds), Pancreatitis-concepts and classification. Elesevier, Amsterdam 1984, pp 291–299.
Gullo L: Value and clinical role of intubation tests in chronic pancreatitis. In: Beger HG, Büchler M, Ditschuneit H, Malfertheiner P (eds), Chronic pancreatitis. Springer, Berlin, Heidelberg, New York, 1988, pp 287–290.
Gullo L: Maximal effective dose of cerulein in the secretin-cerulein test. Digestion 1988;39:225–229.
Ventrucci M, Pezzilli R, Gullo L, Plate L, Sprovieri G, Barbara L: Role of serum pancreatic enzyme assay in diagnosis of pancreatic disease. Dig Dis Sci 1989;34:39–45.
Dominguez-Muñoz JE, Pieramico O, Büchler M, Malfertheiner P: Ratios of different serum pancreatic enzymes in the diagnosis of chronic pancreatitis and in evaluation of the morphological stage. Digestion 1993;54:231–236.
Dürr HK, Otte M, Forrell MM, Bode JC: Fecal chymotrypsin: a study on diagnostic value by comparison with the secretin-cholecystokinin test. Digestion 1978;17:404–409.
Dominguez-Muñoz JE, Hieronymus C, Sauerbruch T, Malfertheiner P: Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995;90:1834–1837.
Stein J, Jung M, Zeuzem S et al.: Fecal-elastase-1: a tubeless test in the diagnosis of pancreatic insuffiency. Gastroenterology 1994;106:A325.
Malfertheiner P, Büchler M, Müller A, Ditschuneit H: Floruescein dilaurate (FDL) serumtest—a rapid tubeless pancreatic function test. Pancreas 1987;2:53–60.
Malfertheiner P, Büchler M, Müller A, Ditschuneit H: Floureszeindilaurat-Serumtest nach Metoclopramid- und Sekretinstimulation zur Pankreasfunktionsprüfung. Beitrag zur Diagnose der chronischen Pankreatitis. Z Gastroenterol 1987;25:225–232.
Malfertheiner P, Büchler M, Müller A, Ditschuneit H: Influence of extrapancreatic digestive disorders on the indirect pancreatic function test with flourescein dilaurate. Clin Physiol Biochem 1985;3:166–173.
Little JM: Alcohol abuse and chronic pancreatitis. Surgery 1987;101:357–360.
Kozarek RA, Patterson DJ, Ball TJ et al.: Endoscopic placement of pancreatic stents and drains in the management of pancreatitis. Ann Surg 1989;209:261–266.
Huibegtse K, Schneider B, Vrij M, Tytgat GNJ: Endoscopic pancreatic drainage in chronic pancreatitis. Gastrointest Endosc 1988;34:9–15.
Girwood AH, Bornman PC, Marks IN: Ductal morphology and pain in chronic alcohol-induced pancreatitis. In: Beger HG, Büchler M, Ditschuneit H, Malfertheiner P (eds.), Chronic pancreatitis, Berlin, Heidelberg, New York, Springer-Verlag 1990. pp 218–220.
Greiner L: Punktionssonografische Alkoholneurolyse der Coeliakalganglien. Dtsch Med Wochenschr 1985;110:833–836.
Madsen P, Hansen E: Coeliac plexus blockade versus pancreaticogatrostomy for pain in chronic pancreatitis. Scand J Gastroenterol 1985;20:1217–1220.
Layer P, Jansen JBMJ, Cherian L, Lamers CBHW, Goebell H: Feedback regulation of human pancreatic secretion: Effect of protease inhibition on duodenal delivery and small intestine transit of pancreatic enzymes. Gastroenterology 1990;98:1311–1319.
Mössner J, Secknus R, Meyer J, Niderau C, Adler G: Treatment of pain with pancreatic extracts in chronic pancreatitis: Results of a placebo-controlled multicenter trial. Digestion 1992;53:54–66.
DiMagno EP, Go VWL, Summerskill WHJ: Relation between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973;288:813–815.
Lankisch PG, Lembcke B, Göke B, Creutzfeldt W: Therapy of pancreatogenic steatorrhoe: does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 1986;24:753–757.
Thiruvengadam R, DiMagno EP: Inactivation of human lipase by proteases. Am J Physiol 1988;255:G476-G481.
Raimondo M, DiMagno EP: Resistence of bacterial lipase to proteolytic digestion: another reason why it may be better than porcine lipase to treat pancreatic steatorrhea. Gastroenterology 1993;104:A445.
Lankisch PG, Lembcke B, Wemken G, Creutzfeldt W: Functional reserve capacity of the exocrine pancreas. Digestion 1986;35:175–181.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
von Arnim, U., Dominguez-Muñoz, J.E. & Malfertheiner, P. Diagnostik und Standards der konservativen Therapie bei chronischer Pankreatitis. Acta Chir Austriaca 28, 217–222 (1996). https://doi.org/10.1007/BF02626008
Issue Date:
DOI: https://doi.org/10.1007/BF02626008